Skip to main content

Betamethasone Acetate/Betamethasone Sodium Phosphate Suspension for Injection

Last Updated: December 8, 2022
Status: Current

Products Affected - Description
    • Celestone Soluspan suspension for injection, Organon, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 78206-0118-01
    • Betamethasone acetate/betamethasone sodium phosphate suspension for injection, American Regent, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00517-0720-01
    • Betamethasone acetate/betamethasone sodium phosphate suspension for injection, Exela Pharma Sciences, 6 mg/mL, 5 mL multiple dose vial, 1 count, NDC 51754-5060-01
Reason for the Shortage
    • American Regent did not provide a reason for the shortage.
    • Exela did not provide a reason for the shortage.
    • Organon did not provide a reason for the shortage.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • American Regent has betamethasone 5 mL vials in limited supply.
    • Exela has betamethasone 5 mL vials on intermittent back order and the company is releasing product monthly.
    • Organon has Celestone Soluspan in 5 mL vials on back order and the company cannot estimate a release date.

Updated

Updated December 8, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 1, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.